MINI LONG - MERCK & CO. Stock

Certificat

DE000KJ3BHL0

Real-time Boerse Frankfurt Warrants 05:09:25 2024-06-13 EDT
2.64 EUR -1.12% Intraday chart for MINI LONG - MERCK & CO.
Current month+23.04%
1 month-1.84%
Date Price Change
24-06-13 2.64 -1.12%
24-06-12 2.67 -2.20%
24-06-11 2.73 +2.25%
24-06-10 2.67 +0.38%
24-06-07 2.66 +4.31%

Real-time Boerse Frankfurt Warrants

Last update June 13, 2024 at 05:09 am

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Citi Citi
WKN KJ3BHL
ISINDE000KJ3BHL0
Date issued 2024-01-04
Strike 102.5 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.02
Lowest since issue 1.45

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.2 USD
Average target price
142.7 USD
Spread / Average Target
+9.59%
Consensus